ML15131A173
| ML15131A173 | |
| Person / Time | |
|---|---|
| Site: | SHINE Medical Technologies |
| Issue date: | 05/01/2015 |
| From: | Bynum R Shine Medical Technologies |
| To: | Office of Nuclear Reactor Regulation |
| Lynch S | |
| References | |
| SHINE, SHINE.SUBMISSION.14, SHN.PSAR.P, SHN.PSAR.P.6 | |
| Download: ML15131A173 (6) | |
Text
Preliminary Safety Analysis Report Master Table of Contents SHINE Medical Technologies i
Rev. 0 Master Table of Contents CHAPTER 1 THE FACILITY
1.1 INTRODUCTION
..................................................................................................... 1-1 1.2
SUMMARY
AND CONCLUSIONS ON PRINCIPAL SAFETY CONSIDERATIONS................................................................................................. 1-2 1.3 GENERAL DESCRIPTION OF THE FACILITY....................................................... 1-8 1.4 SHARED FACILITIES AND EQUIPMENT............................................................... 1-13 1.5 COMPARISON WITH SIMILAR FACILITIES........................................................... 1-14 1.6
SUMMARY
OF OPERATIONS................................................................................ 1-18 1.7 COMPLIANCE WITH THE NUCLEAR WASTE POLICY ACT OF 1982................. 1-19 1.8 FACILITY MODIFICATIONS AND HISTORY.......................................................... 1-20
1.9 REFERENCES
........................................................................................................ 1-21 CHAPTER 2 SITE CHARACTERISTICS 2.1 GEOGRAPHY AND DEMOGRAPHY...................................................................... 2.1-1 2.2 NEARBY INDUSTRIAL, TRANSPORTATION, AND MILITARY FACILITIES.............................................................................................................. 2.2-1 2.3 METEOROLOGY..................................................................................................... 2.3-1 2.4 HYDROLOGY.......................................................................................................... 2.4-1 2.5 GEOLOGY, SEISMOLOGY, AND GEOTECHNICAL ENGINEERING.................... 2.5-1
2.6 REFERENCES
........................................................................................................ 2.6-1 CHAPTER 3 DESIGN OF STRUCTURES, SYSTEMS, AND COMPONENTS 3.1 DESIGN CRITERIA................................................................................................. 3-1 3.2 METEOROLOGICAL DAMAGE.............................................................................. 3-19 3.3 WATER DAMAGE................................................................................................... 3-22 3.4 SEISMIC DAMAGE................................................................................................. 3-25 3.5 SYSTEMS AND COMPONMENTS......................................................................... 3-45 3.5a IRRADIATION FACILITY......................................................................................... 3-57 3.5b RADIOISOTPE PRODUCTION FACILITY.............................................................. 3-94
3.6 REFERENCES
........................................................................................................ 3-107 CHAPTER 4 IRRADIATION UNIT AND RADIOISOTOPE PRODUCTION FACILITY DESCRIPTION 4a1 HETEROGENEOUS REACTOR DESCRIPTION.............................................. 4a1-1 4a2 IRRADIATION FACILITY DESCRIPTION......................................................... 4a2-1 4a2.1
SUMMARY
DESCRIPTION............................................................................ 4a2-2 4a2.2 SUBCRITICAL ASSEMBLY.......................................................................... 4a2-6 Section Title Page
Preliminary Safety Analysis Report Master Table of Contents SHINE Medical Technologies ii Rev. 1 4a2.3 NEUTRON DRIVER..................................................................................... 4a2-20 4a2.4 TARGET SOLUTION VESSEL AND LIGHT WATER POOL............................... 4a2-26 4a2.5 IRRADIATION FACILITY BIOLOGICAL SHIELD.................................................... 4a2-32 4a2.6 NUCLEAR DESIGN................................................................................................. 4a2-37 4a2.7 THERMAL HYDRAULIC DESIGN........................................................................... 4a2-51 4a2.8 GAS MANAGEMENT SYSTEM............................................................................... 4a2-56 4a
2.9 REFERENCES
........................................................................................................ 4a2-62 4b RADIOISOTOPE PRODUCTION FACILITY DESCRIPTION.................................. 4b-1 4b.1 FACILITY AND PROCESS DESCRIPTION............................................................ 4b-2 4b.2 RADIOISOTOPE PRODUCTION FACILITY BIOLOGICAL SHIELD....................... 4b-13 4b.3 RADIOISOTOPE EXTRACTION SYSTEM............................................................. 4b-18 4b.4 SPECIAL NUCLEAR MATERIAL PROCESSING AND STORAGE........................ 4b-27 4b.5 REFERENCES........................................................................................................ 4b-56 CHAPTER 5 COOLING SYSTEMS 5a1 HETEROGENEOUS REACTOR COOLING SYSTEMS.......................................... 5a1-1 5a2 IRRADIATION UNIT COOLING SYSTEMS............................................................. 5a2-1 5a2.1
SUMMARY
DESCRIPTION..................................................................................... 5a2-2 5a2.2 PRIMARY COOLING SYSTEM............................................................................... 5a2-4 5a2.3 SECONDARY COOLING SYSTEM......................................................................... 5a2-13 5a2.4 PRIMARY COOLANT CLEANUP............................................................................ 5a2-20 5a2.5 PRIMARY COOLANT MAKEUP WATER SYSTEM................................................ 5a2-22 5a2.6 NITROGEN-16 CONTROL...................................................................................... 5a2-25 5a2.7 AUXILIARY SYSTEMS USING PRIMARY COOLANT............................................ 5a2-26 5a
2.8 REFERENCES
........................................................................................................ 5a2-27 5b RADIOISOTOPE PRODUCTION FACILITY COOLING SYSTEMS........................ 5b-1 CHAPTER 6 ENGINEERED SAFETY FEATURES 6a1 HETEROGENEOUS REACTOR ENGINEERED SAFETY FEATURES................ 6a1-1 6a2 IRRADIATION FACILITY ENGINEERED SAFETY FEATURES.......................... 6a2-1 6a2.1
SUMMARY
DESCRIPTION............................................................................ 6a2-2 6a2.2 IRRADIATION FACILITY ENGINEERED SAFETY FEATURES DETAILED DESCRIPTION6a2-4 6a2.3 EMERGENCY COOLING SYSTEM........................................................................ 6a2-10 6a2.4 IRRADIATION FACILITY ENGINEERED SAFETY FEATURES TECHNICAL SPECIFICATIONS.............................................................................. 6a2-11 6a
2.5 REFERENCES
........................................................................................................ 6a2-12 6b RADIOISOTOPE PRODUCTION FACILITY ENGINEERED SAFETY FEATURES.............................................................................................................. 6b-1 6b.1
SUMMARY
DESCRIPTION ENGINEERED SAFETY FEATURES......................... 6b-1 6b.2 RADIOISOTOPE PRODUCTION FACILITY ENGINEERED SAFETY FEATURES.............................................................................................................. 6b-3 6b.3 NUCLEAR CRITICALITY CONTROL...................................................................... 6b-11 6b.4 REFERENCES............................................................................................. 6b-23
Preliminary Safety Analysis Report Master Table of Contents SHINE Medical Technologies iii Rev. 0 CHAPTER 7 INSTRUMENTATION AND CONTROL SYSTEMS 7a1 HETEROGENEOUS REACTOR INSTRUMENT & CONTROL SYSTEMS................................................................................................................ 7a1-1 7a2 IRRADIATION FACILITY INSTRUMENT & CONTROL SYSTEMS........................ 7a2-1 7a2.1
SUMMARY
DESCRIPTION..................................................................................... 7a2-1 7a2.2 DESIGN OF INSTRUMENTATION AND CONTROL SYSTEMS............................ 7a2-3 7a2.3 TSV PROCESS CONTROL DESCRIPTION........................................................... 7a2-31 7a2.4 TSV REACTIVITY PROTECTION SYSTEM........................................................... 7a2-33 7a2.5 ENGINEERED SAFETY FEATURES ACTUATION SYSTEM................................ 7a2-37 7a2.6 CONTROL CONSOLE AND DISPLAY INFORMATION.......................................... 7a2-40 7a2.7 RADIATION MONITORING SYSTEMS................................................................... 7a2-43 7a
2.8 REFERENCES
........................................................................................................ 7a2-47 7b RADIOISOTOPE PRODUCTION FACILITY INSTRUMENT &
CONTROL SYSTEM............................................................................................... 7b-1 7b.1
SUMMARY
DESCRIPTION..................................................................................... 7b-1 7b.2 DESIGN OF INSTRUMENTATION AND CONTROL SYSTEMS............................ 7b-2 7b.3 PRODUCTION FACILITY PROCESS CONTROL SYSTEMS................................ 7b-29 7b.4 ENGINEERED SAFETY FEATURE AND ALARMING............................................ 7b-31 7b.5 CONTROL CONSOLE AND DISPLAY INSTRUMENTATION................................ 7b-35 7b.6 RADIATION MONITORING SYSTEMS................................................................... 7b-37 7b.7 REFERENCES........................................................................................................ 7b-38 CHAPTER 8 ELECTRIC POWER SYSTEMS 8a1 HETEROGENEOUS REACTOR ELECTRICAL POWER SYSTEMS..................... 8a1-1 8a2 IRRADIATION UNIT ELECTRICAL POWER SYSTEMS........................................ 8a2-1 8a2.1 NORMAL ELECTRICAL POWER SYSTEMS......................................................... 8a2-1 8a2.2 EMERGENCY ELECTRICAL POWER SYSTEMS.................................................. 8a2-9 8a2.3 IRRADIATION FACILITY ELECTRICAL POWER SYSTEMS TECHNICAL SPECIFICATIONS............................................................................. 8a2-15 8a
2.4 REFERENCES
........................................................................................................ 8a2-16 8b RADIOISOTOPE PRODUCTION FACILITY ELECTRICAL POWER SYSTEMS................................................................................................. 8b-1 8b.1 NORMAL ELECTRICAL POWER SYSTEMS......................................................... 8b-1 8b.2 EMERGENCY ELECTRICAL POWER SYSTEMS.................................................. 8b-2 8b.3 RADIOISOTOPE PRODUCTION FACILITY ELECTRICAL POWER SYSTEMS TECHNICAL SPECIFICATIONS............................................. 8b-3 CHAPTER 9 AUXILIARY SYSTEMS 9a1 HETEROGENEOUS REACTOR AUXILIARY SYSTEMS....................................... 9a1-1 9a2 IRRADIATION FACILITY AUXILIARY SYSTEMS................................................... 9a2-1 9a2.1 HEATING, VENTILATION, AND AIR CONDITIONING SYSTEMS......................... 9a2-1 9a2.2 HANDLING & STORAGE OF TARGET SOLUTION............................................... 9a2-13 9a2.3 FIRE PROTECTION SYSTEMS AND PROGRAMS............................................... 9a2-16
Preliminary Safety Analysis Report Master Table of Contents SHINE Medical Technologies iv Rev. 0 9a2.4 COMMUNICATIONS SYSTEMS............................................................................. 9a2-46 9a2.5 POSSESSION & USE OF BYPRODUCT, SOURCE AND SPECIAL NUCLEAR MATERIAL............................................................................................. 9a2-48 9a2.6 COVER GAS CONTROL IN CLOSED PRIMARY COOLANT SYSTEMS.............. 9a2-50 9a2.7 OTHER AUXILIARY SYSTEMS.............................................................................. 9a2-51 9a2.8 IRRADIATION FACILITY AUXILIARY SYSTEMS TECHNICAL SPECIFICATIONS................................................................................................... 9a2-60 9a
2.9 REFERENCES
........................................................................................................ 9a2-61 9b RADIOISOTOPE PRODUCTION FACILITY AUXILIARY SYSTEMS..................... 9b-1 9b.1 HEATING, VENTILATION, AND AIR CONDITIONING SYSTEMS......................... 9b-1 9b.2 HANDLING & STORAGE OF TARGET SOLUTION............................................... 9b-2 9b.3 FIRE PROTECTION SYSTEMS AND PROGRAMS............................................... 9b-6 9b.4 COMMUNICATION SYSTEMS............................................................................... 9b-7 9b.5 POSSESSION AND USE OF BYPRODUCT, SOURCE AND SPECIAL NUCLEAR MATERIAL............................................................................................. 9b-8 9b.6 COVER GAS CONTROL IN CLOSED PRIMARY COOLANT SYSTEMS.............. 9b-15 9b.7 OTHER AUXILIARY SYSTEMS.............................................................................. 9b-25 9b.8 RADIOISOTOPE PRODUCTION FACILITY AUXILIARY SYSTEMS TECHNICAL SPECIFICATIONS........................................................... 9b-53 9b.6 REFERENCES........................................................................................................ 9b-54 CHAPTER 10 EXPERIMENTAL FACILITIES 10.1
SUMMARY
DESCRIPTION..................................................................................... 10-1 CHAPTER 11 RADIATION PROTECTION PROGRAM AND WASTE MANAGEMENT 11.1 RADIATION PROTECTION..................................................................................... 11-1 11.2 RADIOACTIVE WASTE MANAGEMENT................................................................ 11-42 11.3 RESPIRATORY PROTECTION PROGRAM........................................................... 11-57 11.4 RADIATION PROTECTION PROGRAM AND WASTE MANAGEMENT TECHNICAL SPECIFICATIONS............................................................................. 11-59
11.5 REFERENCES
........................................................................................................ 11-60 CHAPTER 12 CONDUCT OF OPERATIONS 12.1 ORGANIZATION..................................................................................................... 12-1 12.2 REVIEW AND AUDIT ACTIVITIES.......................................................................... 12-5 12.3 PROCEDURES....................................................................................................... 12-7 12.4 REQUIRED ACTIONS............................................................................................. 12-8 12.5 REPORTS............................................................................................................... 12-9 12.6 RECORDS............................................................................................................... 12-10 12.7 EMERGENCY PLANNING...................................................................................... 12-11 12.8 SECURITY PLANNING........................................................................................... 12-12 12.9 QUALITY ASSURANCE.......................................................................................... 12-13 12.10 OPERATOR TRAINING AND REQUALIFICATION................................................ 12-14
Preliminary Safety Analysis Report Master Table of Contents SHINE Medical Technologies v
Rev. 1 12.10a REACTOR OPERATOR TRAINING AND REQUALIFICATION.............................. 12-14 12.10b PRODUCTION FACILITY OPERATOR TRAINING AND REQUALIFICATION................................................................................................ 12-15 12.11 STARTUP PLAN...................................................................................................... 12-16 12.12 VACATED................................................................................................................ 12-17 12.13 MATERIAL CONTROL AND ACCOUNTABILITY PROGRAM................................ 12-18 12.14 REFERENCES........................................................................................................ 12-19 APPENDIX 12A EMERGENCY PLAN...................................................................................... 12A-1 APPENDIX 12B SECURITY PLAN........................................................................................... 12B-1 APPENDIX 12C QUALITY ASSURANCE PROGRAM DESCRIPTION................................... 12C-1 APPENDIX 12D CONDUCT OF OPERATIONS PROGRAM DESCRIPTION......................... 12D-1 CHAPTER 13 ACCIDENT ANALYSIS 13a1 HETEROGENEOUS REACTOR ACCIDENT ANALYSIS....................................... 13a1-1 13a2 IRRADIATION FACILITY ACCIDENT ANALYSIS................................................... 13a2-1 13a2.1 ACCIDENT-INITIATING EVENTS AND SCENARIOS............................................ 13a2-1 13a2.2 ACCIDENT ANALYSIS AND DETERMINATION OF CONSEQUENCES.................................................................................................. 13a2-36 13a3
SUMMARY
AND CONCLUSIONS.......................................................................... 13a3-1 13a4 REFERENCES........................................................................................................ 13a4-1 13b RADIOISOTOPE PRODUCTION FACILITY ACCIDENT ANALYSES.................... 13b-1 13b.1 RADIOISOTOPE PRODUCTION FACILITY ACCIDENT ANALYSIS METHODOLOGY.................................................................................................... 13b-1 13b.2 ANALYSES OF ACCIDENTS WITH RADIOLOGICAL CONSEQUENCES.................................................................................................. 13b-4 13b.3 ANALYSIS OF ACCIDENTS WITH HAZARDOUS CHEMICALS PRODUCED FROM LICENSED MATERIAL........................................................... 13b-37 13b.4 REFERENCES........................................................................................................ 13b-51 CHAPTER 14 TECHNICAL SPECIFICATIONS 14a1 HETEROGENEOUS REACTOR TECHNICAL SPECIFICATIONS......................... 14a1-1 14a2 IRRADIATION FACILITY TECHNICAL SPECIFICATIONS.................................... 14a2-1 14a
2.1 INTRODUCTION
..................................................................................................... 14a2-2 14a2.2 SAFETY LIMITS AND LIMITING SAFETY SYSTEM SETTINGS........................... 14a2-3 14a2.3 LIMITING CONDITIONS FOR OPERATION........................................................... 14a2-4 14a2.4 SURVEILLANCE REQUIREMENTS....................................................................... 14a2-5 14a2.5 DESIGN FEATURES............................................................................................... 14a2-6 14a2.6 ADMINISTRATIVE CONTROLS.............................................................................. 14a2-7 14a
2.7 REFERENCES
........................................................................................................ 14a2-18 14b TECHNICAL SPECIFICATIONS OF PROCESSES OUTSIDE THE IRRADIATION FACILITY......................................................................................... 14b-1 14b.1 INTRODUCTION..................................................................................................... 14b-1 14b.2 SAFETY LIMITS AND LIMITING SAFETY SYSTEM SETTINGS........................... 14b-2 14b.3 LIMITING CONDITIONS FOR OPERATION........................................................... 14b-3 14b.4 SURVEILLANCE REQUIREMENTS....................................................................... 14b-4
Preliminary Safety Analysis Report Master Table of Contents SHINE Medical Technologies vi Rev. 0 14b.5 DESIGN FEATURES............................................................................................... 14b-5 14b.6 ADMINISTRATIVE CONTROLS.............................................................................. 14b-6 14b.7 REFERENCES........................................................................................................ 14b-7 CHAPTER 15 FINANCIAL QUALIFICATIONS 15.1 FINANCIAL ABILITY TO CONSTRUCT THE SHINE FACILITY.......................... 15-1 15.2 FINANCIAL ABILITY TO OPERATE THE SHINE FACILITY............................... 15-3 15.3 FINANCIAL ABILITY TO DECOMMISSION THE SHINE FACILITY..................... 15-5 15.4 FOREIGN OWNERSHIP, CONTROL, OR DOMINATION.................................. 15-6
15.5 NUCLEAR INSURANCE
AND INDEMNITY............................................................ 15-7
15.6 REFERENCES
............................................................................................. 15-8 CHAPTER 16 OTHER LICENSE CONSIDERATIONS 16.1 PRIOR USE OF FACILITY COMPONENTS..................................................... 16-1 16.2 MEDICAL USE OF THE FACILITY.................................................................. 16-2 CHAPTER 17 DECOMMISSIONING AND POSSESSION-ONLY LICENSE AMENDMENTS 17.1 DECOMMISSIONING.............................................................................................. 17-1 17.2 POSSESSION-ONLY LICENSE AMENDMENTS................................................... 17-2 CHAPTER 18 HIGHLY ENRICHED TO LOW ENRICHED URANIUM CONVERSION 18.1 HIGHLY ENRICHED TO LOW ENRICHED URANIUM CONVERSION.................. 18-1 CHAPTER 19 ENVIRONMENTAL REVIEW
19.1 INTRODUCTION
OF THE ENVIRONMENTAL REPORT....................................... 19.1-1 19.2 PROPOSED ACTION.............................................................................................. 19.2-1
19.3 DESCRIPTION
OF THE AFFECTED ENVIRONMENT.......................................... 19.3-1 19.4 IMPACTS OF PROPOSED CONSTRUCTION, OPERATIONS, AND DECOMMISSIONING.............................................................................................. 19.4-1 19.5 ALTERNATIVES...................................................................................................... 19.5-1
19.6 CONCLUSION
S...................................................................................................... 19.6-1
19.7 REFERENCES
........................................................................................................ 19.7-1